Vincerx Pharma, Inc. (VINC) Tops Q4 EPS by 14c
Tweet
Share
E-mailGet Alerts VINC Hot Sheet
Join SI Premium – FREE
Vincerx Pharma, Inc. (NASDAQ: VINC) reported Q4 EPS of ($0.23), $0.14 better than the analyst estimate of ($0.37).
For earnings history and earnings-related data on Vincerx Pharma, Inc. (VINC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
- Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
